This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (790)
Death (76)
Life Threatening Events (30)
Disability (7)
Reports by Reaction Type
Foetal Exposure During Pregnancy (102),
Maternal Exposure During Pregnancy (66),
Abortion Spontaneous (64),
Nephrolithiasis (38),
Renal Failure Acute (35),
Abortion Induced (33),
Viral Load Increased (31),
Pregnancy (29),
Stillbirth (27),
Jaundice (23),
Premature Baby (21),
Renal Impairment (21)
Below are a few examples of reports where side effects / adverse reactions may be related to Reyataz (Atazanavir). For a complete list or a specific selection of reports, please use the links above.
Possible Reyataz side effects in 46 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-27
Patient: 46 year old male
Reactions: Cholelithiasis, Pancreatitis Necrotising
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient: Norvir; Truvada; Crestor
Possible Reyataz side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: 36 year old female
Reactions: Maternal Exposure During Pregnancy, Abortion Induced
Drug(s) suspected as cause:
Reyataz
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Epivir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiviral Treatment
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Viread
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Possible Reyataz side effects in 52 year old female
Reported by a consumer/non-health professional from France on 2012-08-27
Patient: 52 year old female
Reactions: Nephrolithiasis, Septic Shock, Pyelonephritis, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient: Irbesartan; Effexor; Truvada; Sulfamethoxazole and Trimethoprim; Nexium; Vitamin A; Ciprofloxacin Hydrochloride; Norvir; Propranolol
Possible Reyataz side effects in 31 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: 31 year old female
Reactions: Abortion Spontaneous
Drug(s) suspected as cause:
Norvir
Dosage: 100 mg/day taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-08-17
Truvada
Dosage: 1 tab/caps daily taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-08-17
Reyataz
Dosage: 300 mg/day taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-08-17
Possible Reyataz side effects in 52 year old female
Reported by a physician from France on 2012-08-27
Patient: 52 year old female
Reactions: Nephrolithiasis, Septic Shock, Pyelonephritis, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Propranolol; Vitamin A; Truvada; Irbesartan; Ciprofloxacin Hydrochloride; Nexium; Effexor; Norvir
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Foetal Chromosome Abnormality, Spina Bifida, Foetal Exposure During Pregnancy, Arnold-Chiari Malformation, Vertical Talus
Drug(s) suspected as cause:
Truvada
Dosage: 1 df, unk
Start date: 2011-07-13
End date: 2011-10-27
Reyataz
Dosage: 300 mg, qd
Start date: 2011-07-13
End date: 2011-10-27
Combivir
Dosage: 2 df, unk
Start date: 2011-11-21
Norvir
Dosage: 100 mg, qd
Start date: 2011-07-13
End date: 2011-10-27
Isentress
Dosage: 800 mg, qd
Start date: 2011-11-21
Possible Reyataz side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male
Reactions: Congenital Bladder Anomaly, Urethral Valves, Congenital Hydronephrosis, Foetal Exposure During Pregnancy, Bladder Obstruction, Congenital Renal Disorder
Drug(s) suspected as cause:
Lisinopril
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Atorvastatin
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: female
Reactions: Pulmonary Hypertension, Syndactyly, Congenital Hand Malformation, Patent Ductus Arteriosus, Ventricular Septal Defect, Single Umbilical Artery
Drug(s) suspected as cause:
Emtricitabine / Tenofovir Disoproxil Fumarate
Dosage: 1 df, qd
Indication: HIV Infection
Start date: 2012-01-25
Reyataz
Dosage: 300 mg, qd
Indication: HIV Infection
Start date: 2012-01-25
Zidovudine
Dosage: 2 mg/kg, q1hr
Indication: Antiretroviral Therapy
Start date: 2012-05-22
End date: 2012-05-22
Zidovudine
Dosage: 1 mg/kg, q1hr
Start date: 2012-05-22
End date: 2012-05-22
Ritonavir
Dosage: 100 mg, qd
Indication: HIV Infection
Start date: 2012-01-25
Possible Reyataz side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: 36 year old female
Reactions: Abortion Induced
Drug(s) suspected as cause:
Viread
Administration route: Oral
Indication: Antiretroviral Therapy
Epivir
Administration route: Oral
Indication: Antiretroviral Therapy
Norvir
Dosage: daily
Administration route: Oral
Indication: Antiretroviral Therapy
Reyataz
Administration route: Oral
Indication: Antiretroviral Therapy
Possible Reyataz side effects in 66 year old male
Reported by a physician from Japan on 2012-08-24
Patient: 66 year old male
Reactions: Glomerulonephritis Chronic
Drug(s) suspected as cause:
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-15
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-15
Epzicom
Dosage: 1df: 1tab
Administration route: Oral
Indication: HIV Infection
Start date: 2007-06-27
Other drugs received by patient: Depakene
Possible Reyataz side effects in 35 year old male
Reported by a physician from Japan on 2012-08-24
Patient: 35 year old male
Reactions: Renal Impairment, Cytomegalovirus Chorioretinitis, Hypoaesthesia, Mycobacterium Avium Complex Infection, Hyperuricaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Valganciclovir
Administration route: Oral
Indication: Cytomegalovirus Chorioretinitis
Start date: 2010-05-19
End date: 2010-06-30
Valganciclovir
Administration route: Oral
Start date: 2010-07-01
End date: 2011-01-20
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2009-10-22
End date: 2011-03-31
Mycobutin
Administration route: Oral
Indication: Mycobacterium Avium Complex Infection
Start date: 2009-11-20
End date: 2009-12-11
Epzicom
Administration route: Oral
Indication: HIV Infection
Start date: 2009-12-11
End date: 2010-09-20
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2009-10-22
End date: 2009-12-02
Prezista
Administration route: Oral
Indication: HIV Infection
Start date: 2009-12-03
End date: 2011-03-31
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2009-10-22
End date: 2009-12-02
Valganciclovir
Administration route: Oral
Indication: Cytomegalovirus Infection
Start date: 2010-01-06
End date: 2010-06-30
Valganciclovir
Administration route: Oral
Indication: Mycobacterium Avium Complex Infection
Start date: 2010-02-16
End date: 2010-03-24
Other drugs received by patient: Isentress; Pentamidine Isethionate; Intelence; Semen Coicis; Clindamycin Phosphate; Chlorhexidine Gluconate
Possible Reyataz side effects in 26 year old female
Reported by a physician from United States on 2012-08-23
Patient: 26 year old female
Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced
Drug(s) suspected as cause:
Truvada
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Reyataz
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Combivir
Dosage: 2tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Raltegravir
Dosage: 800mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Possible Reyataz side effects in
Reported by a physician from United States on 2012-08-23
Patient: , weighing 1.9 kg (4.2 pounds)
Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation
Drug(s) suspected as cause:
Norvir
Dosage: 100mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Truvada
Dosage: 1tab per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Combivir
Dosage: 2tab per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Raltegravir
Dosage: 800mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Reyataz
Dosage: 300mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Possible Reyataz side effects in female
Reported by a physician from Japan on 2012-08-21
Patient: female
Reactions: Renal Impairment, Diarrhoea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Reyataz
Dosage: 300 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2005-01-06
End date: 2011-05-30
Norvir
Dosage: 100 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2011-04-27
End date: 2011-05-30
Tenofovir Disoproxil Fumarate
Dosage: 300 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2005-01-06
End date: 2011-05-30
Other drugs received by patient: Candesartan Cilexetil; Epivir; Isentress; Candesartan Cilexetil; Zyrtec; Epzicom
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient: female
Reactions: Amniotic Fluid Volume Decreased, Abortion Spontaneous
Drug(s) suspected as cause:
Norvir
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-01-24
Truvada
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-01-24
Reyataz
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-01-24
Possible Reyataz side effects in male
Reported by a physician from France on 2012-08-21
Patient: male
Reactions: Dysmorphism, Foetal Exposure During Pregnancy, Renal Dysplasia, Intestinal Malrotation, Persistent Cloaca, Trisomy 21, Bladder Dilatation, Cleft Palate, Protrusion Tongue, Renal Aplasia, LOW SET Ears, Abdominal Distension, Anal Atresia, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: female
Reactions: Pulmonary Hypertension, Syndactyly, Congenital Hand Malformation, Patent Ductus Arteriosus, Ventricular Septal Defect, Single Umbilical Artery
Drug(s) suspected as cause:
Reyataz
Dosage: 300 mg, qd
Indication: HIV Infection
Start date: 2012-01-25
Emtricitabine / Tenofovir Disoproxil Fumarate
Dosage: 1 df, qd
Indication: HIV Infection
Start date: 2012-01-25
Zidovudine
Dosage: 2 mg/kg, q1hr
Indication: Antiretroviral Therapy
Start date: 2012-05-22
End date: 2012-05-22
Zidovudine
Dosage: 1 mg/kg, q1hr
Start date: 2012-05-22
End date: 2012-05-22
Ritonavir
Dosage: 100 mg, qd
Indication: HIV Infection
Start date: 2012-01-25
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient:
Reactions: Vertical Talus
Drug(s) suspected as cause:
Lamivudine + Zidovudine
Dosage: 2 df, qd
Indication: HIV Infection
Start date: 2011-11-21
Emtricitabine / Tenofovir Disoproxil Fumarate
Dosage: 1 df, qd
Indication: HIV Infection
Start date: 2011-07-13
End date: 2011-10-27
Ritonavir
Dosage: 100 mg, qd
Indication: HIV Infection
Start date: 2011-07-13
End date: 2011-10-27
Reyataz
Dosage: 300 mg, qd
Indication: HIV Infection
Start date: 2011-07-13
End date: 2011-10-27
Raltegravir
Dosage: 800 mg, qd
Indication: HIV Infection
Start date: 2011-11-21
Possible Reyataz side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: male
Reactions: Bladder Dilatation, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: male
Reactions: Urethral Valves, Congenital Hydronephrosis
Drug(s) suspected as cause:
Atorvastatin
Indication: Blood Triglycerides Increased
Lisinopril
Indication: Hypertension
Reyataz
Dosage: 300 mg, qd
Indication: HIV Infection
Emtricitabine / Tenofovir Disoproxil Fumarate
Dosage: 1 df, qd
Indication: HIV Infection
Zidovudine
Dosage: unk
Indication: HIV Infection
Start date: 2011-10-13
End date: 2011-10-13
Zidovudine
Dosage: unk
Ritonavir
Dosage: 100 mg, qd
Indication: HIV Infection
Atorvastatin
Indication: LOW Density Lipoprotein Increased
Possible Reyataz side effects in male
Reported by a physician from United States on 2012-08-17
Patient: male, weighing 3.7 kg (8.1 pounds)
Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis
Drug(s) suspected as cause:
Truvada
Dosage: 1tab per day
Indication: Antiretroviral Therapy
End date: 2011-11-10
Combivir
Dosage: 2tab per day
Indication: Antiretroviral Therapy
Start date: 2011-11-10
End date: 2012-06-07
Norvir
Dosage: 100mgd per day
Indication: Antiretroviral Therapy
Reyataz
Dosage: 300mgd per day
Indication: Antiretroviral Therapy
Other drugs received by patient: Retrovir; Fluconazole; Terazol Cream; Retrovir; Unspecified Medication
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient:
Reactions: Cytogenetic Abnormality, Brain Malformation, Spina Bifida, Abortion Induced, Vertical Talus
Adverse event resulted in: death
Drug(s) suspected as cause:
Isentress
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Combivir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: female, weighing 3.7 kg (8.1 pounds)
Reactions: Neurofibromatosis, Foetal Exposure During Pregnancy, Cafe AU Lait Spots
Drug(s) suspected as cause:
Truvada
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient:
Reactions: Foetal Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in female
Reported by a physician from France on 2012-08-17
Patient: female
Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault
Adverse event resulted in: death
Drug(s) suspected as cause:
Truvada
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: male, weighing 3.7 kg (8.2 pounds)
Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Combivir
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: male
Reactions: Bladder Dilatation, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Truvada
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in female
Reported by a physician from France on 2012-08-16
Patient: female
Reactions: Oligohydramnios, Abortion Induced, Pregnancy
Drug(s) suspected as cause:
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-24
Norvir
Dosage: 1 film coated tablet daily
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-24
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2011-01-24
Possible Reyataz side effects in male
Reported by a consumer/non-health professional from France on 2012-08-16
Patient: male
Reactions: Bladder Dilatation, Dysmorphism, Renal Aplasia, Anal Atresia, Intestinal Malrotation, Persistent Cloaca, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Start date: 2012-01-24
Norvir
Dosage: 1 film coated tablet daily
Start date: 2012-01-24
Truvada
Start date: 2011-01-24
Possible Reyataz side effects in 35 year old male
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: 35 year old male
Reactions: Road Traffic Accident
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient: Carvedilol; Olanzapine; Exforge; Metformin Hydrochloride; Ritonavir; Ibuprofen; Truvada
|